Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carbonic anhydrase II knockout (
Car2
-/-
) mice have depleted numbers of renal intercalated cells, which are increasingly recognized to be innate immune effectors. We compared
pyelonephritis
susceptibility following reciprocal renal transplantations between
Car2
-/-
and wild-type mice. We examined the effect of pharmacological CA suppression using acetazolamide in an experimental murine model of urinary tract infection.
Car2
-/-
versus wild-type mice were compared for differences in renal innate immunity. In our transplant scheme, mice lacking CA-II in the kidney had increased
pyelonephritis
risk. Mice treated with acetazolamide had lower kidney bacterial burdens at 6 h postinfection, which appeared to be due to tubular flow from diuresis because comparable results were obtained when furosemide was substituted for acetazolamide. Isolated
Car2
-/-
kidney cells enriched for intercalated cells demonstrated altered intercalated cell innate immune gene expression, notably increased
calgizzarin
and insulin receptor expression. Intercalated cell number and function along with renal tubular flow are determinants of
pyelonephritis
risk.
...
PMID:Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility. 3239 May 12